Khaberni - The U.S. Department of Health and Human Services announced that the Food and Drug Administration (FDA) is conducting a comprehensive investigation into deaths that might be associated with coronavirus (COVID-19) vaccines, covering multiple age groups.
Department spokesperson Andrew Nixon said on Tuesday that the age groups under investigation have not yet been determined.
FDA Commissioner Marty Makary earlier stated that the administration is investigating these deaths among the young.
The administration's chief medical and scientific officer, Vinay Prasad, revealed in an internal memo last month the possibility that the vaccines contributed to the deaths of at least 10 children due to myocarditis, based on a preliminary analysis of 96 death cases between 2021 and 2024.
These results have not been published in a peer-reviewed scientific journal, nor did they include details about the health status of the victims or the manufacturers of the vaccines.
The announcement coincided with reports published by Bloomberg and The Washington Post regarding the investigation.
In late November, The New York Times reported that the U.S. Food and Drug Administration mentioned in an internal memo that at least 10 children likely died "because of" COVID-19 vaccines, referring to myocarditis as a possible cause.
"Vaccine Enemy"
Since the appointment of Robert Kennedy as Health Minister, the government has begun a comprehensive overhaul of vaccine policy, limiting access for those aged 65 or older, as well as those suffering from underlying medical conditions.
Kennedy has long been skeptical about the efficacy of vaccines, stating during the coronavirus (COVID-19) pandemic that vaccines cause injuries and deaths, accused the director of the National Institute of Allergy and Infectious Diseases and the Bill and Melinda Gates Foundation of trying to financially profit from the pandemic, opposed restrictions imposed by states and the federal government during the pandemic, and accused of spreading misleading information.
Department spokesperson Andrew Nixon declined to reveal the methodology of the investigation or the timeline for its completion, while health experts expressed concerns about the impact of new political trends on the FDA’s work, warning that the ongoing controversy could undermine public trust in globally proven vaccination programs despite the recording of rare side effects.
Commenting on the U.S. Food and Drug Administration's investigation, Moderna and Pfizer reaffirmed their commitment to the safety of their vaccines based on messenger RNA (mRNA) technology and renewed confirmation of no new concerns regarding vaccine safety in children or pregnant women.
